Catalyst Pharmaceuticals (CPRX) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.25% |
| Dec 31, 2025 | 43.24% |
| Sep 30, 2025 | 46.70% |
| Jun 30, 2025 | 53.77% |
| Mar 31, 2025 | 54.39% |
| Dec 31, 2024 | 52.99% |
| Sep 30, 2024 | 51.22% |
| Jun 30, 2024 | 50.04% |
| Mar 31, 2024 | 48.56% |
| Dec 31, 2023 | 34.70% |
| Sep 30, 2023 | 33.20% |
| Jun 30, 2023 | 50.04% |
| Mar 31, 2023 | 51.17% |
| Dec 31, 2022 | 49.52% |
| Sep 30, 2022 | 51.03% |
| Jun 30, 2022 | 50.62% |
| Mar 31, 2022 | 59.32% |
| Dec 31, 2021 | 57.86% |
| Sep 30, 2021 | 48.84% |
| Jun 30, 2021 | 41.20% |
| Mar 31, 2021 | 35.58% |
| Dec 31, 2020 | 31.09% |
| Sep 30, 2020 | 71.56% |
| Jun 30, 2020 | 54.00% |
| Mar 31, 2020 | 46.23% |
| Dec 31, 2019 | 39.15% |
| Sep 30, 2019 | 28.74% |
| Jun 30, 2019 | 16.93% |
| Mar 31, 2019 | 4.41% |
| Dec 31, 2018 | 0.19% |
| Sep 30, 2018 | 1.60% |
| Jun 30, 2018 | 2.82% |
| Mar 31, 2018 | 1.33% |
| Dec 31, 2017 | 24.82% |
| Sep 30, 2017 | -8.93% |
| Jun 30, 2017 | -7.82% |
| Mar 31, 2017 | 19.25% |
| Dec 31, 2016 | 18.02% |
| Sep 30, 2016 | 16.45% |
| Jun 30, 2016 | 57.42% |
| Dec 31, 2015 | 52.97% |
| Mar 31, 2015 | 147.95% |
| Dec 31, 2014 | 91.53% |
| Sep 30, 2014 | 120.13% |
| Jun 30, 2014 | 101.55% |
| Dec 31, 2013 | 63.25% |